Moderna Inc
(NASDAQ:MRNA)
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
top performing MRNA trades
![Daniel Goldman headshot](https://clerk.house.gov/content/assets/img/members/G000599.jpg)
Daniel Goldman
House (D-NY)
-19.60%
![Josh Gottheimer headshot](https://clerk.house.gov/content/assets/img/members/G000583.jpg)
Josh Gottheimer
House (D-NJ)
-30.40%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Moderna trades made by congress members.
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Mar 07, 2024 | Feb 01, 2024 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Oct 15, 2023 | Sep 15, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Aug 13, 2023 | Jul 12, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Purchase | May 19, 2023 | Apr 10, 2023 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Purchase | Apr 20, 2023 | Mar 31, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $50K - $100K | stock | Sale | Apr 17, 2023 | Mar 06, 2023 | House |
![]() Josh GottheimerHouse (D-NJ) | $1K - $15K | stock | Sale | Apr 17, 2022 | Mar 16, 2022 | House |